Egr-1 Expression During Neointimal Development in Flow-Associated Pulmonary Hypertension-Reference-Cited by-同舟云学术

Egr-1 Expression During Neointimal Development in Flow-Associated Pulmonary Hypertension

Published:2011-11 Issue:5 Volume:179 Page:2199-2209
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Dickinson Michael G.,Bartelds Beatrijs,Molema Grietje,Borgdorff Marinus A.,Boersma Bibiche,Takens Janny,Weij Michel,Wichers Pieter,Sietsma Hannie,Berger Rolf M.F.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference36 articles.

1. Possibilities and impossibilities in the evaluation of pulmonary vascular disease in congenital heart defects;Berger;Eur Heart J,2000

2. Biopsy pathology of the pulmonary vasculature;Wagenvoort,1989

3. Reversible or irreversible remodeling in pulmonary arterial hypertension;Sakao;Am J Respir Cell Mol Biol,2010

4. Cellular and molecular pathobiology of pulmonary arterial hypertension;Humbert;J Am Coll Cardiol,2004

5. Pathogenic mechanisms of pulmonary arterial hypertension;Chan;J Mol Cell Cardiol,2008

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Smooth muscle Cxcl12 activation is associated with vascular remodeling in flow-induced pulmonary hypertension;2024-09-10

2. Differentially Expressed Genes and Pathways between Reversible and Irreversible Pulmonary Arterial Hypertension Associated with Congenital Heart Disease Investigated by Bioinformatics Analysis in Rat Model;2023-09-05

3. Early Growth Response-1: Friend or Foe in the Heart?;Heart, Lung and Circulation;2023-05

4. Transgelin exacerbates pulmonary artery smooth muscle cell dysfunction in shunt‐related pulmonary arterial hypertension;ESC Heart Failure;2022-07-15

5. Cell-to-Cell Crosstalk: A New Insight into Pulmonary Hypertension;Reviews of Physiology, Biochemistry and Pharmacology;2022